- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02897570
Metabolic and Neurofunctional Responses to Breakfasts
Effect of Glucose Versus Mixed Breakfast on Metabolic and Neurofunctional Responses in Healthy Individuals
This study aims at assessing the effects of glucose and different types of breakfast on metabolic and neurofunctional responses in healthy individuals.
Twelve healthy subjects, on a stable diet, in a randomized-crossover fashion, received either a 50 g glucose load (control) or one of these breakfast:
B1: milk (125ml) and cereals (30g); B2: milk (220ml), apple (200g) and cream chocolate filled sponge cake (30g); B3: milk (125ml), bread (50g), apple (150g) and hazelnut cream chocolate (15g). Prior and upon completion of each tolerance test, an EEG was performed to measure frontal P300-evoked potentials.
Study Overview
Status
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
MI
-
San Donato Milanese, MI, Italy, 20097
- San Donato Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI 18.5 - 24.9 kg/m2
- normal glucose tolerance
- stable diet
Exclusion Criteria:
- type 1 and type 2 diabetes
- impaired glucose tolerance
- dyslipidemia
- metabolic syndrome
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Glucose
EEG_pre + Oral glucose tolerance test (50-g OGTT) + EEG_post
|
50g of glucose dissolved in 250 to 300ml of water was drunk.
Prior and upon completion of each glucose tolerance test, an EEG was performed.
Electroencephalography (EEG) was performed prior each tolerance test to assess frontal P300-evoked potentials
Electroencephalography (EEG) was performed upon completion of each tolerance test to assess frontal P300-evoked potentials
|
Experimental: Milk + Cereals
EEG_pre + B1: milk (125ml) and cereals (30g) + EEG_post
|
Electroencephalography (EEG) was performed prior each tolerance test to assess frontal P300-evoked potentials
Electroencephalography (EEG) was performed upon completion of each tolerance test to assess frontal P300-evoked potentials
A breakfast (B1) including a glass of milk (125ml) and 30 g-corn flakes was consumed.
Prior and upon completion of each tolerance test, an EEG was performed
A breakfast (B2) including a glass of milk (220ml), an apple (200g), a cream chocolate filled sponge cake (30g) was consumed.
Prior and upon completion of each meal tolerance test, an EEG was performed.
|
Experimental: Milk + Apple + Snack
EEG_pre + B2: milk (220ml), apple (200g) and cream chocolate filled sponge cake (30g) + EEG_post
|
Electroencephalography (EEG) was performed prior each tolerance test to assess frontal P300-evoked potentials
Electroencephalography (EEG) was performed upon completion of each tolerance test to assess frontal P300-evoked potentials
A breakfast (B1) including a glass of milk (125ml) and 30 g-corn flakes was consumed.
Prior and upon completion of each tolerance test, an EEG was performed
A breakfast (B3) including a glass of milk (125ml), an apple (150g), bread (50g, hazelnut chocolate cream (15g) was consumed.
Prior and upon completion of each meal tolerance test, an EEG was performed.
|
Experimental: Milk + Apple + Bread w/ cream
EEG_pre + B3: milk (125ml), apple (150g), and bread (50g) with hazelnut chocolate cream (15g) + EEG_post
|
Electroencephalography (EEG) was performed prior each tolerance test to assess frontal P300-evoked potentials
Electroencephalography (EEG) was performed upon completion of each tolerance test to assess frontal P300-evoked potentials
A breakfast (B1) including a glass of milk (125ml) and 30 g-corn flakes was consumed.
Prior and upon completion of each tolerance test, an EEG was performed
A breakfast (B3) including a glass of milk (125ml), an apple (150g), bread (50g, hazelnut chocolate cream (15g) was consumed.
Prior and upon completion of each meal tolerance test, an EEG was performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of glucose vs different kind of breakfasts on cognitive performances via brain evoked-potentials measure
Time Frame: The incremental (post-pre) frontal P300 potential was assessed as a "change" ( before and 180 min after consumption)
|
On the same morning of the glucose tolerance test, before and 180 min after consumption, an EEG was performed to record P300 wave-evoked potentials.
|
The incremental (post-pre) frontal P300 potential was assessed as a "change" ( before and 180 min after consumption)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of glucose vs different kind of breakfasts on AUC_glycemia in healthy subjects
Time Frame: Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion.
|
The incremental area under plasma glucose concentration curve (AUC_glycemia) was used as summary measures of the metabolic responses resulting from the intake of either glucose or one of the 3 breakfasts.
The incremental AUC was calculated as the difference between the total AUC and the product of the basal, pre-test concentration time during the experiment (i.e., 120 min).
|
Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion.
|
Effect of glucose vs different kind of breakfasts on AUC_ghrelinemia in healthy subjects.
Time Frame: Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion.
|
The incremental area under plasma ghrelin concentration curve (AUC_ghrelinemia) was used as summary measures of the metabolic responses resulting from the intake of either glucose or one of the 3 breakfasts.
The incremental AUC was calculated as the difference between the total AUC and the product of the basal, pre-test concentration time during the experiment (i.e., 120 min).
|
Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion.
|
Effect of glucose vs different kind of breakfasts on AUC_insulinemia in healthy subjects.
Time Frame: Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion.
|
The incremental area under plasma insulim concentration curve (AUC_insulinemia) was used as summary measures of the metabolic responses resulting from the intake of either glucose or one of the 3 breakfasts.
The incremental AUC was calculated as the difference between the total AUC and the product of the basal, pre-test concentration time during the experiment (i.e., 120 min).
|
Blood samples are drawn at -15, 0, 15, 30, 45, 60, 75, 90, 120 minutes with respect to the ingestion.
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001 Aug;50(8):1714-9. doi: 10.2337/diabetes.50.8.1714.
- Barclay AW, Brand-Miller JC, Wolever TM. Glycemic index, glycemic load, and glycemic response are not the same. Diabetes Care. 2005 Jul;28(7):1839-40. doi: 10.2337/diacare.28.7.1839. No abstract available.
- Franz MJ. The glycemic index: not the most effective nutrition therapy intervention. Diabetes Care. 2003 Aug;26(8):2466-8. doi: 10.2337/diacare.26.8.2466. No abstract available.
- Esposito K, Giugliano D. Low-glycemic load diet and resting energy expenditure. JAMA. 2005 Mar 9;293(10):1189; auhor reply 1189-90. doi: 10.1001/jama.293.10.1189-a. No abstract available.
- Benedini S, Codella R, Caumo A, Marangoni F, Luzi L. Different circulating ghrelin responses to isoglucidic snack food in healthy individuals. Horm Metab Res. 2011 Feb;43(2):135-40. doi: 10.1055/s-0030-1269900. Epub 2011 Jan 10.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Colazioni/4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit and Disruptive Behavior Disorders
-
National Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit and Disruptive Behavior DisorderUnited States
-
Baylor College of MedicineCompletedAttention Deficit and Disruptive Behavior Disorders | Attention Deficit Hyperactivity DisorderUnited States
-
Erzurum Regional Training & Research HospitalCompletedAttention Deficit and Disruptive Behavior DisordersTurkey
-
University of PittsburghNational Institute of Mental Health (NIMH); University of Michigan; NYU Langone... and other collaboratorsRecruitingAttention Deficit and Disruptive Behavior Disorders | Child Behavior ProblemUnited States
-
New York UniversityCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder | Disruptive BehaviorUnited States
-
Oregon Research InstituteNational Institute on Drug Abuse (NIDA)CompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Child Disruptive Behavior DisordersUnited States
-
National Institute of Mental Health (NIMH)CompletedAttention Deficit Hyperactivity Disorder | Mood Disorder | Attention Deficit and Disruptive Behavior Disorder | Mental Disorder Diagnosed in ChildhoodUnited States
-
Chiba UniversityCompletedAttention Deficit and Disruptive Behavior Disorders | Hyperkinesis | Attention Deficit Disorder With Hyperactivity DiseaseJapan
-
University of South CarolinaUniversity of Georgia; Oregon Research Institute; The University of QueenslandCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Childhood Disruptive Behavior Disorders | Parent-Child InteractionsUnited States
-
Tufts Medical CenterNational Institute of Mental Health (NIMH)CompletedAttention Deficit and Disruptive Behavior Disorders | Attention Deficit Disorder With HyperactivityUnited States
Clinical Trials on Glucose
-
University of Texas Southwestern Medical CenterCompletedSarcoma | Neuroblastoma | Pediatric CancerUnited States
-
Children's Mercy Hospital Kansas CityWithdrawnType 1 DiabetesUnited States
-
University of Massachusetts, WorcesterNot yet recruitingPregnancy, High Risk | Type 2 Diabetes Treated With InsulinUnited States
-
Glostrup University Hospital, CopenhagenUnknown
-
Makassed General HospitalCompleted
-
US Department of Veterans AffairsEmory UniversityCompletedType 2 Diabetes Mellitus | Prediabetic StateUnited States
-
NestléCompletedHealthyNew Zealand
-
Unilever R&DLeiden University Medical CenterCompleted